Circulating tumor cells in small-cell lung cancer: A predictive and prognostic factor

Annals of Oncology

Volumn 23, Issue 11, 2012, Pages 2937-2942

  Hiltermann, T J N ^a   Pore, M M ^a   Van den Berg, A ^a   Timens, W ^a   Boezen, H M ^a   Liesker, J J W ^b   Schouwink, J H ^c   Wijnands, W J A ^d   Kerner, G S M A ^a   Kruyt, F A E ^a   Tissing, H ^e,f   Tibbe, A G J ^e,f   Terstappen, L W M M ^g   Groen, H J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Scheper Ziekenhuis   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d DEVENTER HOSPITAL   (Netherlands)

^e Immunicon Corporation   (United States)

^f Veridex LCC   (United States)

^g UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Circulating tumor cells; Prognosis; Small cell lung cancer; Treatment prediction

Indexed keywords

PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CELL COUNT; CIRCULATING TUMOR CELL; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PLATINUM COMPOUNDS; PROGNOSIS; PROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84868106386     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds138     Document Type: Article

References (27)

1. Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539-4544.
2. Simon GR, Turrisi A, American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 324S-339S.
3. Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10: 6897-6904.
4. Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-791.
5. de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14: 6302-6309.
6. Matsusaka S, Chìn K, Ogura M et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010; 101: 1067-1071.
7. Krebs MG, Sloane R, Priest L et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011; 29: 1556-1563.
8. Cohen SJ, Punt CJA, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26: 3213-3221.
9. Hou JM, Greystoke A, Lancashire L et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 2009; 175: 808-816.
10. Naito T, Tanaka F, Ono A et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol 2012; 7: 512-519.
11. Budd GT, Cristofanilli M, Ellis MJ et al. Circulating tumor cells versus imaging- predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12: 6403-6409.
12. De Giorgi U, Valero V, Rohren E et al. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Ann Oncol 2010; 21: 33-39.
13. Vallieres E, Shepherd FA, Crowley J et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4: 1049-1059.
14. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
15. Chinn S. Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 1991; 46: 454-456.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
17. Wu C, Hao H, Li L et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol 2009; 4: 30-36.
18. Bevilacqua S, Gallo M, Franco R et al. A 'live' biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer 2009; 65: 123-125.
19. Brezicka T. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4. Acta Oncol 2005; 44: 723-727.
20. Sorensen M, Pijls-Johannesma M, Felip E, ESMO Guidelines Working Group. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v120-v125.
21. Brambilla E, Moro D, Gazzeri S et al. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J Clin Oncol 1991; 9: 50-61.
22. Furuse K, Fukuoka M, Nishiwaki Y et al. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group. J Clin Oncol 1998; 16: 2126-2132.
23. McDowell EM, Trump BF. Pulmonary smell cell carcinoma showing tripartite differentiation in individual cells. Hum Pathol 1981; 12: 286-294.
24. Wicha M, Hayes D. Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J Clin Oncol 2011; 29: 1508-1511.
25. Shepherd FA, Crowley J, Van Houtte P et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2: 1067-1077.
26. de Jong WK, Fidler V, Groen HJ. Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer. Clin Lung Cancer 2007; 8: 376-381.
27. Sargent DJ, Hayes DF. Assessing the measure of a new drug: is survival the only thing that matters? J Clin Oncol 2008; 26: 1922-1923.